Belimumab
Medicine
B-cell activating factor
Internal medicine
Placebo
Clinical endpoint
Systemic lupus erythematosus
Lupus erythematosus
Adverse effect
Randomized controlled trial
Clinical trial
Connective tissue disease
Immunology
Antibody
Disease
Autoimmune disease
B cell
Pathology
Alternative medicine